According to the Medicinal Products in Human Medicine Act, the State regulates the limit prices of the medicinal products subject to medical prescription and the prices of the medicinal products on the positive list of medicines which are paid with public funds according to the lowest reference prices in the EU Member States.
The Ordinance on the Terms, Rules and Procedure for Regulation and Registration of Prices for Medicinal products determines 10 countries to which Bulgaria refers: Belgium, Greece, Spain, Italy, Latvia, Lithuania, Romania, Slovakia, Slovenia and France.
04.04.2018 Prices of medicinal products with a symbol * in column No./Date of the Decision (Column T) of Annex 4 of the Positive Drug List (ceiling prices of medicinal products included in the Positive Drug List) should not be used for external pricing reference, of the relevant update of Annex 4.
The administrative act, which accepted the change of the price, has not been enforced by Bulgarian legislation, but the preliminary enforcement of the decision has been ordered.
The information is updated on 1/08/2019